Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major ...

The open-label, multicenter, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of RNDO-564 both as a monotherapy and in combination ...

COLLEGE SPORTS. NOW TO A KCRA THREE EXCLUSIVE. FOR THE FIRST TIME, WE’RE HEARING FROM AB HERNANDEZ, THE TRANSGENDER HIGH SCHOOL TRACK AND FIELD ATHLETE WHO WAS PROTESTED LAST WEEK AT THE CIF ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

Research led by the University of Washington reports on an AI-guided method that designs epitope-specific antibodies and confirms atomically precise binding using high-resolution molecular imaging, ...

View post: Costco Drops $2,200 Off ‘Top Notch' Osaki OS-4D Pro Maestro Massage Chair in a Great Deal View post: Why You Wake Up at 3 A.M. Why You Wake Up at 3 A.M. View post: This Award-Winning ...

The MarketWatch News Department was not involved in the creation of this content. NASHVILLE, Tenn., Oct. 2, 2025 /PRNewswire/ -- AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. On TikTok, vagus nerve stimulation sounds like a miracle cure ...

The FDA approved the Altaviva implantable nerve stimulator for urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB), Medtronic announced. Inserted near the ankle in a ...

OKLAHOMA CITY (KFOR) — One Oklahoma Nurse Practitioner is trying to provide relief for patients by using a drug-free option. It’s approved by the FDA, and after Congress implemented the No Pain Act in ...

After facing national scrutiny for competing in California's track and field finals, a transgender athlete from Jurupa Valley responded to the critics who believe she does not belong in girls' sports.

Treatment with efgartigimod IV was associated with a statistically significant and clinically meaningful improvement in MG-ADL total score compared with placebo. Topline results were announced from a ...